Cigna expects revenue gains from launches of Humira biosimilars
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Cigna Corp. (CI) tops earnings, but misses revenue expectations
February 3, 2023 12:09 PM ESTCigna Corp. (NYSE: CI) reported earnings for its latest quarter before the opening bell Friday, topping earnings but missing revenue consensus expectations.
While the earnings beat was enough to push the company's share price higher at the start of the session, the revenue miss and conservative guidance have weighed on Cigna shares, which are currently down 0.65% on the day.
The managed healthcare and insurance company reported earnings of $4.96 per share on revenue of $45.75 billion, beating... More
Cigna Corp. (CI) tops earnings, but misses revenue expectations
February 3, 2023 12:09 PM ESTCigna Corp. (NYSE: CI) reported earnings for its latest quarter before the opening bell Friday, topping earnings but missing revenue consensus expectations.
While the earnings beat was enough to push the company's share price higher at the start of the session, the revenue miss and conservative guidance have weighed on Cigna shares, which are currently down 0.65% on the day.
The managed healthcare and insurance company reported earnings of $4.96 per share on revenue of $45.75 billion, beating... More
